Haosun is one of 100 medium technical enterprises which government promotes to develop. It passed GMP authentication in 2005, and ISO9001, ISO14001, OHSMS18001 system authentication in 2006. Haosun was approved by FDA for Flumazenil and Granisetron Hydrochloride in May 2007.

We take the purpose of "Good medicine for people" and adhere the strategy of "high tech, high grade, low cost, broad influence, internationalization", we can continuously improve product quality¡¢production environment and occupational health & safety system and promote progress of our technology and management through performing the system certification of ISO9001, ISO14000 and OHSMS18000. Haosun has more than 100 staffs, including 30 senior technicians. Haosun has established 6 API production lines, the new ointment production line has completed and solid production line
is in the process of installation. All of these are equipped with an advanced quality management and inspection system to ensure the good quality of product. We pay attention to the environmental protection, follow the principle of clean production, we have a comprehensive sewage treatment facilities, all of the treated waste water reused 100%. Haosun has more than ten kinds of main products for domestic market, such as Erythromycin Ehylsuccin, Hydrotalcite, Nifedipine, Hydroxy-camptothecin, N-(2)-L-alanyl-L-glutamine , etc. We have won the trust of the domestic customers due to good quality and stability and the competitive price. On the international market, some products of high added value and high-tech are sold
to Europe and America, such as Granisetron Hydrochloride, Flumazenil, Mitoxantrone Hydrochloride, Irinotecan Hydrochloride, Docetaxel, Oxaliplatin, Pramipexole Hydrochloride,etc. Granisetron Hydrochloride and Flumazenil have passed the inspection of USFDA. We follow the rule of "international marketing "and promote progress of technology & management and achieve a win-win goal of international and domestic markets. We strive to pass the EU or FDA site inspection with 2-3 products in each of next year, and gain the European COS certification, sell the products to Europe and USA. At the same time we will manage following the modern enterprise management system at the end of 2008, and strive to achieve the ultimate goal of the overseas listing between 2010 and 2011. We make "Haosun Pharmaceutical" to be influence brand and produce more and better products for society, benefit for mankind.